CONCORDBIO
Concord Biotech Limited
Pharmaceuticals
Share price
₹1,331
Market cap
₹13,913 Cr
1Y return
▼ 17%
An R&D-driven biopharma company engaged in manufacturing fermentation-based active pharmaceutical ingredients for immunosuppressants and oncology applications. Established in 1984, the company specializes in complex fermentation technology and serves domestic and international pharmaceutical markets with differentiated API solutions. Its focus on bioprocess innovation and vertical integration in fermentation-based manufacturing distinguishes it within the competitive global pharmaceutical ingredients landscape.
Investors holding Concord Biotech Limited
Recent moves 4
DSP Mutual FundNew position
DSP Mutual Fund bought 12,88,114 shares of Concord Biotech Limited for ₹180.86 Cr at ₹1404.10 apiece in a bulk deal.
Read more
Government Pension Fund Global (Norway)Decreased
Government Pension Fund Global (Norway) decreased its stake in Concord Biotech Limited from 2.99% to 2.95%, selling 36,910 shares.
Read more
Max Life InsuranceDecreased
Max Life Insurance decreased its stake in Concord Biotech Limited from 1.52% to 1.34%, selling 187,698 shares. The value of the shares sold is ₹25.2 Cr at a share price of ₹1342.80.
Read more
Tata AIA Life InsuranceIncreased
Tata AIA Life Insurance increased its stake in Concord Biotech from 1.91% to 2.48% by purchasing 595,891 shares, bringing its total holdings to 2,590,472 shares. The additional shares are valued at ₹80.00 Cr at a price of ₹1342.80 apiece.
Read more
Track the whales in Concord Biotech Limited
Get alerted the moment a top investor buys or sells.
Get started